Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epirubicin”

235 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 235 results

Large-scale testing (Phase 3)UnknownNCT01204801
What this trial is testing

Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer Tumors

Who this might be right for
Breast Cancer
Medifocus, Inc. 238
Testing effectiveness (Phase 2)Active Not RecruitingNCT04067037
What this trial is testing

Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's Lymphoma

Who this might be right for
Classical Hodgkin Lymphoma
Henan Cancer Hospital 60
Large-scale testing (Phase 3)Study completedNCT00429871
What this trial is testing

Randomized Phase III Trial With Docetaxel Plus Epirubicine Versus Docetaxel Plus Capecitabine for Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hellenic Oncology Research Group 272
Testing effectiveness (Phase 2)WithdrawnNCT01205217
What this trial is testing

Lapatinib or Trastuzumab Given Prior to Surgery With Chemotherapy in Patients With Early Breast Cancer

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline
Testing effectiveness (Phase 2)Study completedNCT00375999
What this trial is testing

Docetaxel and Epirubicin in Advanced Gastric Cancer

Who this might be right for
Stomach Neoplasms
Yonsei University 34
Testing effectiveness (Phase 2)Study completedNCT00378313
What this trial is testing

Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer

Who this might be right for
Stage IIB Breast CancerStage IIIA Breast CancerStage IIIB Breast Cancer+3 more
NSABP Foundation Inc 76
Testing effectiveness (Phase 2)Ended earlyNCT00193024
What this trial is testing

Epirubicin and Docetaxel in the Treatment of Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
SCRI Development Innovations, LLC 90
Large-scale testing (Phase 3)Study completedNCT01216644
What this trial is testing

5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer

Who this might be right for
Gastric Cancer
Krankenhaus Nordwest 716
Large-scale testing (Phase 3)UnknownNCT00039546
What this trial is testing

Combination Chemotherapy in Treating Women With Breast Cancer Who Have Undergone Surgery

Who this might be right for
Breast Cancer
Cancer Research Campaign Clinical Trials Centre
Testing effectiveness (Phase 2)Study completedNCT00601705
What this trial is testing

Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomach

Who this might be right for
Esophageal CancerGastric Cancer
Case Comprehensive Cancer Center 61
Testing effectiveness (Phase 2)Ended earlyNCT00176488
What this trial is testing

Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
University of Medicine and Dentistry of New Jersey 31
Testing effectiveness (Phase 2)Study completedNCT00645866
What this trial is testing

Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast Cancer

Who this might be right for
Breast Cancer
Mayo Clinic 47
Testing effectiveness (Phase 2)Looking for participantsNCT07320508
What this trial is testing

Epirubicin Interventional Chemotherapy for Sinonasal Adenoid Cystic Carcinoma (SNACC): A Prospective Study

Who this might be right for
Adenoid Cystic CarcinomaSinonasal CarcinomaEpirubicin
Eye & ENT Hospital of Fudan University 100
Testing effectiveness (Phase 2)UnknownNCT02115152
What this trial is testing

Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast Cancer

Who this might be right for
Stage II Breast CancerStage III Breast Cancer
Guangxi Medical University 100
Large-scale testing (Phase 3)Study completedNCT00002784
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer

Who this might be right for
Breast Cancer
ETOP IBCSG Partners Foundation 344
Early research (Phase 1)Study completedNCT00878904
What this trial is testing

Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
University of California, San Francisco 40
Large-scale testing (Phase 3)UnknownNCT04490993
What this trial is testing

Safety and Efficacy of APL-1202 in Combination With Epirubicin Hydrochloride Versus Epirubicin Hydrochloride Alone in Intermediate and High-risk Chemo-refractory Non-muscle Invasive Bladder Cancer (NMIBC) Patients

Who this might be right for
Non-muscle Invasive Bladder Cancer
Jiangsu Yahong Meditech Co., Ltd aka Asieris 359
Testing effectiveness (Phase 2)Study completedNCT01593020
What this trial is testing

Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 54
Not applicableStudy completedNCT00630240
What this trial is testing

Risk Factors for the Leakage of Anticancer Drugs to Systemic Circulation by Transcatheter Arterial Chemoembolization

Who this might be right for
Hepatocellular Carcinoma
Kaohsiung Medical University Chung-Ho Memorial Hospital 53
Large-scale testing (Phase 3)Study completedNCT01150513
What this trial is testing

Docetaxel+Carboplatin vs Epirubicin+Cyclophosphamide Followed by Docetaxel as Adjuvant Treatment in Triple-negative Breast Cancer

Who this might be right for
Breast Cancer
Chinese Academy of Medical Sciences 320
Next Page